Treatment of nut midline carcinoma

• 收藏
• 分享

专利权人:

Inc.;Tensha Therapeutics

发明人:

Landau, Steven B.,Kagey, Michael H.

申请号：

AU2016283020

公开号：

AU2016283020A1

申请日:

2016.06.24

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

Disclosed herein is a method of treating nuclear protein in testis (NUT) midline carcinoma (NMC) in a subject in need thereof, comprising administering an effective amount of a bromodomain inhibitor, wherein the effective amount can be determined according to the expression levels of CD11b, which monitors responsiveness of the NMC to the bromodomain inhibitor. Also disclosed herein is a method of determining a bromodomain inhibitor treatment regimen in a subject suffering from NMC.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/